Polygenic Risk Score (PRS)

Personalised Prevention for Patients with Dyslipidaemia, Hypertension, and Elevated hs-CRP: The Key to Optimal Cardiovascular Care

by Prateek Chopra | June 16, 2026 | Cardiology Conferences | ESH 2026 Background and Rationale: Cardiovascular disease (CVD) prevention is increasingly shifting from a population-based model to a personalized approach that integrates genetic risk, traditional risk factors, and inflammatory biomarkers. Precision medicine can enhance prevention strategies in patients with dyslipidemia, hypertension, and elevated inflammatory burden. Genetic Risk Assessment: Hemodynamic-Guided Hypertension […]

Personalised Prevention for Patients with Dyslipidaemia, Hypertension, and Elevated hs-CRP: The Key to Optimal Cardiovascular Care Read Post »

Leave a Comment / ESH Day 4 / bluetree.healthcare@gmail.com / July 29, 2026 / High-Sensitivity C-Reactive Protein (hs-CRP), Hypertension Management, Pharmacogenomics, Polygenic Risk Score (PRS), Precision Cardiovascular Medicine

Integrated Polygenic Scores: Are They Ready for Clinical Practice?

by Prateek Chopra | June 7, 2026 | Cardiology Conferences | ESH 2026 Precision Cardiovascular Prevention: Integrated polygenic risk scores (PRS) enhance risk stratification beyond traditional risk factors. PRS predicts coronary artery disease (CAD) 2–4 times more strongly than conventional risk factors and identifies high-risk individuals not captured by family history or standard clinical assessments. High-Risk Populations: Evidence from Clinical Trials: